上海口腔医学 ›› 2026, Vol. 35 ›› Issue (5): 543-548.doi: 10.19439/j.sjos.2026.05.017

• 论著 • 上一篇    下一篇

益生菌对种植体周组织疾病干预的效果评价

杨紫茜, 黄莹, 杨旭   

  1. 沧州市人民医院 口腔科,河北 沧州 061000
  • 收稿日期:2025-03-31 修回日期:2025-06-15 发布日期:2026-11-05
  • 通讯作者: 黄莹,E-mail:424497739@qq.com
  • 作者简介:杨紫茜(1991—),女,本科,主治医师,E-mail:yzq52010y@163.com
  • 基金资助:
    2021年度沧州市科技计划自筹经费项目(213106009)

Evaluation of the intervention effect of probiotics on peri-implant tissue diseases

Yang Ziqian, Huang Ying, Yang Xu   

  1. Department of Stomatology, Cangzhou People's Hospital. Cangzhou 061000, Hebei Province, China
  • Received:2025-03-31 Revised:2025-06-15 Published:2026-11-05

摘要: 目的: 探讨益生菌联合常规治疗对种植体周组织疾病患者的干预效果,重点分析其对临床指标[探诊深度(probe depth,PD)、临床附着水平(clinical attachment leve,CAL)、探诊出血(bleeding on probing,BOP)]及口腔微生物群落结构的影响,为临床治疗提供循证依据。方法: 选取 2022年1月—2023年12月沧州市人民医院收治的111例种植体周组织疾病患者,采用随机对照设计分为益生菌组(55例)和对照组(56例)。两组均接受机械清洁+超声龈下刮治,益生菌组在此基础上每天服用含乳酸杆菌和双歧杆菌的益生菌制剂(2×109 CFU /天),对照组服用安慰剂,疗程均为12周。治疗前后检测 PD、CAL、BOP,通过 16S rRNA 高通量测序分析唾液及龈下菌斑微生物群落,同时检测龈沟液及唾液中炎症因子(IL-1β、TNF-α、CRP)水平,并记录不良反应。结果: 治疗后12周,益生菌组PD从(4.7±0.8) mm降至(3.1±0.5) mm,对照组从(4.6±0.7) mm 降至(3.7±0.6) mm,差异有统计学意义(P<0.01)。益生菌组CAL从(5.5±1.0) mm改善至(4.1±0.8) mm,对照组从(5.4±1.1) mm 改善至(4.7±0.9 ) mm,差异有统计学意义(P<0.05);益生菌组BOP率从65%降至25%,对照组从67%降至40%,差异有统计学意义(P<0.01)。生物群落分析结果表明,益生菌组病原菌比例显著下降同时有益菌群比例显著增加(P<0.01)。炎症因子方面,益生菌组IL-1β、TNF-α及CRP在治疗后均显著下降(P<0.01),且显著低于对照组(P<0.01)。两组均未出现严重不良反应。结论: 益生菌联合常规治疗可显著改善种植体周组织疾病患者的临床症状,优化口腔微生物群落结构,抑制炎症反应,安全性良好,具有较高的临床应用价值。

关键词: 益生菌, 种植体周组织疾病, 探诊深度, 临床附着水平, 微生物群落, 16S rRNA, 炎症因子

Abstract: PURPOSE: To explore the intervention effect of probiotics combined with conventional treatment on patients with peri-implant diseases, focusing on analyzing its impact on clinical indicators [probe depth (PD), clinical attachment level (CAL), bleeding on probing (BOP)] and the structure of the oral microbial community, so as to provide evidence-based basis for clinical treatment. METHODS: A total of 111 patients with peri-implant diseases admitted to Cangzhou People's Hospital from January 2022 to December 2023 were selected and divided into the probiotic group (n=55) and control group (n=56) using a randomized controlled design. Both groups received mechanical cleaning + ultrasonic subgingival scaling. On this basis, the probiotic group took a probiotic preparation containing Lactobacillus and Bifidobacterium daily (2×109 CFU/d), while the control group took a placebo. The treatment course for both groups was 12 weeks. Before and after treatment, PD, CAL, and BOP were measured; the microbial communities in saliva and subgingival plaque were analyzed via 16S rRNA high-throughput sequencing; meanwhile, the levels of inflammatory factors (IL-1β, TNF-α, CRP) in gingival crevicular fluid and saliva were detected, and adverse reactions were recorded. RESULTS: After 12 weeks of treatment, PD in the probiotic group decreased from (4.7±0.8) mm to (3.1±0.5) mm, while PD in the control group decreased from (4.6±0.7) mm to (3.7±0.6) mm, with significant difference (P<0.01). CAL in the probiotic group improved from (5.5±1.0) mm to (4.1±0.8) mm, while CAL in the control group improved from (5.4±1.1) mm to (4.7±0.9) mm, with a statistically significant difference (P<0.05); the rate of BOP in the probiotic group decreased from 65% to 25%, while the rate of BOP in the control group decreased from 67% to 40%, with significant difference (P<0.01). The results of microbial community analysis showed that the proportion of pathogenic bacteria in the probiotic group decreased significantly, while the proportion of beneficial bacteria increased significantly (P<0.01). In terms of inflammatory factors, the levels of IL-1β, TNF-α, and CRP in the probiotic group decreased significantly after treatment (P<0.01), and were significantly lower than those in the control group (P<0.01). No severe adverse reactions occurred in either group. CONCLUSIONS: Probiotics combined with conventional treatment can significantly improve the clinical symptoms of patients with peri-implant diseases, optimize the structure of oral microbial community, inhibit the inflammatory response with good safety, which has high clinical application value.

Key words: Probiotics, Peri-implant disease, Probing depth, Clinical attachment level, Microbial community, 16S rRNA, Inflammatory factors

中图分类号: